|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
FY2022
12 months to Apr 30, 2022
|
FY2021
12 months to Apr 30, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling and administrative expenses | |||||
| Impairment of goodwill | |||||
| Operating income | |||||
| Other income | |||||
| Change in fair value of warrants | |||||
| Interest expense | |||||
| Loss before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net (loss) income from continuing operations | |||||
| Loss before tax from discontinued operations | |||||
| Tax benefit from discontinued operations | |||||
| Net loss from discontinued operations | |||||
| Net loss | |||||
| (Loss) income from continuing operations | |||||
| Loss from discontinued operations | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted-average shares of common stock outstanding | |||||
| Basic | |||||
| Diluted | |||||
Loading...